Agriterra moots sugar move 03/07/2009
Phil Edmonds’ African food group Agriterra expects a turnaround to profits as it contemplates a move into sugar.
Gene specialist Silence Therapeutics would not comment today on City suggestions of a major drug group tie-up.
Drug giant AstraZeneca holds nearly three per cent of Silence, a leading specialist in RNA (ribonucleic acid) interference, which can repress genes linked to the onset of disease. The Square Mile is abuzz with suggestions that Astra or another major pharmaceutical concern is interested in a corporate deal.
Finance director Melvyn Davies says the company is ‘in talks at all times’ about potential product licensing deals. A Silence adviser insists the company does not comment on rumours.
At 108p, this former growth stock retains some speculative appeal.
Growth Company Investor subscribers have full access to all our AIM and small-cap share recommendations.
To subscribe today with a half-price offer and gain immediate access to all the recommendations, click here.
Advertisement
Get 20% bonus on your first deposit and a financial advisor serving you 24/7. For experienced traders – xforex extreme feature – follow our top trader LIVE!
The new survey into new AIM companies focusing on IPO activity over the closing months of 2008. The report itself contains information on the brokers who are most able to raise cash in the current environment and the sectors that are attracting institutional investment. Buy the new issues on Aim research report.
In the first ever deep analysis of trading values and volumes on AIM, Growth Company Investor, in association with BDO Stoy Hayward, will be shining their research light on the pre-eminent companies on AIM. Buy the Liquidity Drivers on AIM research report today.
The fifth annual examination of the entire AIM market, detailing the fastest growing companies on the junior market, aswell as the most profitable and the least profitable businesses. Buy the Spotlight on AIM 2009 research report today.
Business XL, the award-winning monthly magazine for growing companies, is delighted to announce the launch of a new study on cash shells. The research provides a comprehensive overview of cash shells on AIM, companies that have become a significant feature on the AIM landscape. Buy Cash Shells 2009 Research Report today.
Advertisement
Phil Edmonds’ African food group Agriterra expects a turnaround to profits as it contemplates a move into sugar.
‘Smart metering’ specialist Bglobal has obtained up to £15 million asset funding from Barclays Asset Sales & Finance.
Jubilee Platinum is offering shares to buy fellow AIM counter, smelting and refining specialist Braemore Resources.